UFP Technologies, Inc. (NASDAQ:UFPT) Shares Purchased by De Lisle Partners LLP

Key Points

• De Lisle Partners LLP has increased its stake in UFP Technologies by 17.9%, making it the fifth largest position within their portfolio, now representing 2.7% of their total holdings.
• UFP Technologies reported a quarterly earnings per share of $2.47, exceeding analyst expectations of $2.05, and also achieved revenue of $148.15 million, surpassing estimates.
• Analysts at Lake Street Capital have set a price objective of $252.00 on UFP Technologies' stock, maintaining a "buy" rating.

De Lisle Partners LLP boosted its holdings in shares of UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 17.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 79,802 shares of the industrial products company's stock after buying an additional 12,129 shares during the quarter. UFP Technologies makes up about 2.7% of De Lisle Partners LLP's investment portfolio, making the stock its 5th largest holding. De Lisle Partners LLP owned approximately 1.04% of UFP Technologies worth $16,114,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the company. Johnson Financial Group Inc. purchased a new stake in UFP Technologies during the fourth quarter valued at $42,000. Lazard Asset Management LLC purchased a new stake in UFP Technologies during the fourth quarter valued at $84,000. Park Square Financial Group LLC bought a new position in UFP Technologies during the fourth quarter valued at $107,000. Canada Pension Plan Investment Board increased its position in UFP Technologies by 25.0% during the fourth quarter. Canada Pension Plan Investment Board now owns 500 shares of the industrial products company's stock valued at $122,000 after acquiring an additional 100 shares during the last quarter. Finally, Dakota Wealth Management bought a new position in UFP Technologies during the first quarter valued at $204,000. Hedge funds and other institutional investors own 87.28% of the company's stock.

Analyst Ratings Changes

Separately, Lake Street Capital set a $252.00 price target on shares of UFP Technologies and gave the stock a "buy" rating in a report on Wednesday, May 7th.

Insider Activity at UFP Technologies

In other news, SVP Christopher P. Litterio sold 1,473 shares of the firm's stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $220.12, for a total transaction of $324,236.76. Following the sale, the senior vice president owned 12,585 shares of the company's stock, valued at $2,770,210.20. This trade represents a 10.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.40% of the stock is owned by insiders.

UFP Technologies Stock Down 0.0%

Shares of UFPT stock traded down $0.02 during mid-day trading on Friday, hitting $226.37. 67,880 shares of the stock traded hands, compared to its average volume of 136,005. The stock has a market cap of $1.75 billion, a P/E ratio of 27.70 and a beta of 1.11. The stock's fifty day moving average is $238.93 and its two-hundred day moving average is $233.78. UFP Technologies, Inc. has a 52-week low of $178.26 and a 52-week high of $366.41. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.58 and a quick ratio of 1.45.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The industrial products company reported $2.47 earnings per share for the quarter, topping the consensus estimate of $2.05 by $0.42. UFP Technologies had a net margin of 11.59% and a return on equity of 21.27%. The company had revenue of $148.15 million for the quarter, compared to the consensus estimate of $139.93 million.

About UFP Technologies

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.